Related Experiment Video
Updated: Jan 28, 2026

Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos
Published on: May 12, 2020
[Protein repair therapy in cystic fibrosis]
Annick Clément1, Aline Tamalet, Brigitte Fauroux
1Service de pneumologie pédiatrique Centre de la mucoviscidose Hôpital Armand-Trousseau 75571 Paris. annick.clement@trs.ap-hop-paris.fr
Abstract:
In the past few years since the cloning of the gene defective in cystic fibrosis, much has been learned on the function of the protein cystic fibrosis transmembrane conductance regulator (CFTR) and on the mechanisms regulating its expression. Based on the current understanding of the processes involved in lung disease progression, a number of approaches have been developed using not only gene therapy, but also pharmacological agents. Several of these agents have been reported to restore function to CFTR with specific mutations.
Insights
Researchers are developing gene therapies and drugs to treat cystic fibrosis by targeting the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Some agents show promise in restoring CFTR function for specific mutations.
Area of Science:
- Molecular Biology
- Genetics
- Pharmacology
Context:
- Cystic Fibrosis (CF) is a genetic disorder.
- The cloning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene has advanced understanding of CF.
- Lung disease progression in CF involves complex mechanisms.
Purpose:
- To explore therapeutic strategies for cystic fibrosis.
- To investigate the function and regulation of the CFTR protein.
- To develop agents that can restore CFTR function.
Summary:
- Significant progress has been made in understanding CFTR protein function and gene expression regulation.
- Therapeutic approaches include gene therapy and pharmacological agents.
- Several agents are being developed to restore function to CFTR mutations.
Impact:
- Potential for new treatments for cystic fibrosis.
- Improved understanding of CFTR protein's role in disease.
- Development of targeted therapies for specific CFTR mutations.
More Related Videos
15:12Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
Published on: May 10, 2014
14:56Expression and Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein in Saccharomyces cerevisiae
Published on: March 10, 2012
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Mismatch Repair
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Nucleotide Excision Repair
Overview of DNA Repair
Chemically...